Načítá se...
Precision Therapy of Pancreatic Cancer: From Bench to Bedside
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC), with a mortality rate of 94% and a 5-year-survival rate of only 8%, is one of the deadliest cancer entities worldwide, and early diagnostic methods as well as effective therapies are urgently needed. SUMMARY: This review summarizes current clinica...
Uloženo v:
| Vydáno v: | Visc Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger GmbH
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590788/ https://ncbi.nlm.nih.gov/pubmed/33178734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509232 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|